190 related articles for article (PubMed ID: 28923347)
1. Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production.
Tubbs E; Axelsson AS; Vial G; Wollheim CB; Rieusset J; Rosengren AH
Mol Cell Endocrinol; 2018 Feb; 461():205-214. PubMed ID: 28923347
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.
Tubbs E; Theurey P; Vial G; Bendridi N; Bravard A; Chauvin MA; Ji-Cao J; Zoulim F; Bartosch B; Ovize M; Vidal H; Rieusset J
Diabetes; 2014 Oct; 63(10):3279-94. PubMed ID: 24947355
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Mechanisms Underlying Mitochondria-Associated Endoplasmic Reticulum Membrane-Induced Insulin Resistance.
Cheng H; Gang X; He G; Liu Y; Wang Y; Zhao X; Wang G
Front Endocrinol (Lausanne); 2020; 11():592129. PubMed ID: 33329397
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Mitochondria-Associated Membranes (MAMs) by NO/sGC/PKG Participates in the Control of Hepatic Insulin Response.
Bassot A; Chauvin MA; Bendridi N; Ji-Cao J; Vial G; Monnier L; Bartosch B; Alves A; Cottet-Rousselle C; Gouriou Y; Rieusset J; Morio B
Cells; 2019 Oct; 8(11):. PubMed ID: 31731523
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-associated endoplasmic reticulum membranes allow adaptation of mitochondrial metabolism to glucose availability in the liver.
Theurey P; Tubbs E; Vial G; Jacquemetton J; Bendridi N; Chauvin MA; Alam MR; Le Romancer M; Vidal H; Rieusset J
J Mol Cell Biol; 2016 Apr; 8(2):129-43. PubMed ID: 26892023
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the mitochondria-associated ER membrane (MAM) plays a central role in palmitic acid-induced insulin resistance.
Shinjo S; Jiang S; Nameta M; Suzuki T; Kanai M; Nomura Y; Goda N
Exp Cell Res; 2017 Oct; 359(1):86-93. PubMed ID: 28827061
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane Balances Ca
Tian S; Lei P; Zhang J; Sun Y; Li B; Shan Y
Mol Nutr Food Res; 2021 Jul; 65(14):e2001076. PubMed ID: 33929090
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Integrity Contributes to Muscle Insulin Resistance in Mice and Humans.
Tubbs E; Chanon S; Robert M; Bendridi N; Bidaux G; Chauvin MA; Ji-Cao J; Durand C; Gauvrit-Ramette D; Vidal H; Lefai E; Rieusset J
Diabetes; 2018 Apr; 67(4):636-650. PubMed ID: 29326365
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis.
Beaulant A; Dia M; Pillot B; Chauvin MA; Ji-Cao J; Durand C; Bendridi N; Chanon S; Vieille-Marchiset A; Da Silva CC; Patouraux S; Anty R; Iannelli A; Tran A; Gual P; Vidal H; Gomez L; Paillard M; Rieusset J
J Hepatol; 2022 Sep; 77(3):710-722. PubMed ID: 35358616
[TBL] [Abstract][Full Text] [Related]
10. Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance.
Rieusset J; Fauconnier J; Paillard M; Belaidi E; Tubbs E; Chauvin MA; Durand A; Bravard A; Teixeira G; Bartosch B; Michelet M; Theurey P; Vial G; Demion M; Blond E; Zoulim F; Gomez L; Vidal H; Lacampagne A; Ovize M
Diabetologia; 2016 Mar; 59(3):614-23. PubMed ID: 26660890
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase α2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo.
Wu S; Lu Q; Ding Y; Wu Y; Qiu Y; Wang P; Mao X; Huang K; Xie Z; Zou MH
Circulation; 2019 Apr; 139(16):1913-1936. PubMed ID: 30646747
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
Stacchiotti A; Favero G; Lavazza A; Golic I; Aleksic M; Korac A; Rodella LF; Rezzani R
PLoS One; 2016; 11(1):e0148115. PubMed ID: 26824477
[TBL] [Abstract][Full Text] [Related]
13. Study of Endoplasmic Reticulum and Mitochondria Interactions by In Situ Proximity Ligation Assay in Fixed Cells.
Tubbs E; Rieusset J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060261
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-associated ER membranes in glucose homeostasis and insulin resistance.
Townsend LK; Brunetta HS; Mori MAS
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1053-E1060. PubMed ID: 32985254
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 modulates ER-mitochondria crosstalk to mediate superparamagnetic iron oxide nanoparticles induced hepatotoxicity: an
Che L; Yao H; Yang CL; Guo NJ; Huang J; Wu ZL; Zhang LY; Chen YY; Liu G; Lin ZN; Lin YC
Nanotoxicology; 2020 Mar; 14(2):162-180. PubMed ID: 31703536
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes.
Duponchel S; Monnier L; Molle J; Bendridi N; Alam MR; Gaballah A; Grigorov B; Ivanov A; Schmiel M; Odenthal M; Ovize M; Rieusset J; Zoulim F; Bartosch B
JHEP Rep; 2023 Mar; 5(3):100647. PubMed ID: 36718430
[TBL] [Abstract][Full Text] [Related]
17. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
[TBL] [Abstract][Full Text] [Related]
18. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity.
Arruda AP; Pers BM; Parlakgül G; Güney E; Inouye K; Hotamisligil GS
Nat Med; 2014 Dec; 20(12):1427-35. PubMed ID: 25419710
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 inhibition impairs endoplasmic reticulum-mitochondria contact in hepatic cells and augments gluconeogenesis by increasing VDAC1 levels.
Nandwani A; Rathore S; Datta M
Redox Biol; 2024 Feb; 69():102989. PubMed ID: 38100882
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.
Hudecova S; Markova J; Simko V; Csaderova L; Stracina T; Sirova M; Fojtu M; Svastova E; Gronesova P; Pastorek M; Novakova M; Cholujova D; Kopacek J; Pastorekova S; Sedlak J; Krizanova O
Oncotarget; 2016 Sep; 7(38):61403-61418. PubMed ID: 27528021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
